Tag: Pharmather - Page 4 - Psychedelic Alpha

Read more about the article PharmaTher Announces Positive Research Results for Psilocybin Microneedle Patch

PharmaTher Announces Positive Research Results for Psilocybin Microneedle Patch

Post published:November 11, 2021
Post category:Press Release

Read more about the article PharmaTher Enters into Research Collaboration Agreement with Revive Therapeutics for Development of Psilocybin Microneedle Patch

PharmaTher Enters into Research Collaboration Agreement with Revive Therapeutics for Development of Psilocybin Microneedle Patch

Post published:November 3, 2021
Post category:Press Release

Read more about the article World Leading Drug Delivery Researcher Professor Ryan Donnelly Joins PharmaTher as Scientific and Technical Advisor

World Leading Drug Delivery Researcher Professor Ryan Donnelly Joins PharmaTher as Scientific and Technical Advisor

Post published:October 27, 2021
Post category:Press Release

Read more about the article PharmaTher Engages Alcami for Clinical and Commercial Manufacturing of Novel Ketamine Products

PharmaTher Engages Alcami for Clinical and Commercial Manufacturing of Novel Ketamine Products

Post published:October 19, 2021
Post category:Press Release

Read more about the article PharmaTher Granted FDA Orphan Drug Designation For Ketamine To Treat Complex Regional Pain Syndrome

PharmaTher Granted FDA Orphan Drug Designation For Ketamine To Treat Complex Regional Pain Syndrome

Post published:October 13, 2021
Post category:Press Release

Read more about the article PharmaTher Initiates Phase 2 Clinical Trial of Ketamine for the Treatment of Parkinson’s Disease

PharmaTher Initiates Phase 2 Clinical Trial of Ketamine for the Treatment of Parkinson’s Disease

Post published:October 6, 2021
Post category:Press Release

Read more about the article PharmaTher Retains Former FDA Psychiatry Division Director Dr. Thomas Laughren as Regulatory Affairs Advisor

PharmaTher Retains Former FDA Psychiatry Division Director Dr. Thomas Laughren as Regulatory Affairs Advisor

Post published:September 29, 2021
Post category:Press Release

Read more about the article PharmaTher Announces Closing of CAD$10 Million Private Placement with Institutional Investors

PharmaTher Announces Closing of CAD$10 Million Private Placement with Institutional Investors

Post published:September 28, 2021
Post category:Press Release

Read more about the article PharmaTher Announces CAD$10 Million Private Placement With Institutional Investors

PharmaTher Announces CAD$10 Million Private Placement With Institutional Investors

Post published:September 24, 2021
Post category:Press Release

Read more about the article PharmaTher Provides Product Pipeline Updates and Anticipated Milestones for Q4-2021 and 2022

PharmaTher Provides Product Pipeline Updates and Anticipated Milestones for Q4-2021 and 2022

Post published:September 13, 2021
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.